Entry Detail



General Information

Database ID:exR0000441
RNA Name:AKAP17A
RNA Type:mRNA
Chromosome:chrX
Starnd:+
Coordinate:
Start Site(bp):1591604End Site(bp):1602520
External Links:ENSG00000197976



Disease Information

Disease Name:Down Syndrome
Disease Category:Congenital, Hereditary, and Neonatal Diseases and Abnormalities
MeSH ID:D004314
Type:Diseases Category/Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Alias:Syndrome, Down//Mongolism//47,XY,+21//Trisomy G//47,XX,+21//Down's Syndrome//Downs Syndrome//Syndrome, Down's//Trisomy 21//Trisomy 21, Mitotic Nondisjunction//Down Syndrome, Partial Trisomy 21//Partial Trisomy 21 Down Syndrome//Trisomy 21, Meiotic Nondisjunction



Expression Detail

GEO ID:GSE16176
Description:Expression profiles of amniotic fluid from human fetuses with Down syndrome and euploid controls
Experimental Design:Disease vs Control
Case Disease Type:Down Syndrome
Case Disease SubType:NA
Case Sample:Down Syndrome
Control Sample:Normal
Number of Case:7
Number of Control:7
Number of Samples:14





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
LASP1
chr17
38869859
38921770
+
TKT
chr3
53224712
53256052
-
RPL13
chr16
89560657
89566828
+
RAB11FIP3
chr16
425649
523011
+
UNCX
chr7
1232872
1237326
+
ARFRP1
chr20
63698642
63708025
-
UBA5
chr3
132654446
132678097
+
FDPS
chr1
155308748
155320666
+
BSG
chr19
571277
583493
+
CSDE1
chr1
114716913
114758676
-
PI4KA
chr22
20707691
20859417
-
FBXW5
chr9
136940435
136944738
-
MAP3K15
chrX
19360056
19515261
-
PGM1
chr1
63593411
63660245
+
NOA1
chr4
56963350
56977606
-
CDC42EP5
chr19
54465026
54473296
-
HNRNPA1P48
chr16
51553436
51647132
+
TOB1
chr17
50862223
50867978
-
TMUB1
chr7
151081085
151083493
-
GNAS
chr20
58839718
58911192
+
EEF2
chr19
3976056
3985463
-
TMSB4X
chrX
12975110
12977227
+
MATR3
chr5
139273752
139331671
+
SIGMAR1
chr9
34634722
34637809
-
HLA-DMA
chr6
32948613
32969094
-
ZNF48
chr16
30378106
30400108
+
STARD3NL
chr7
38178222
38230671
+
SNRPN
chr15
24823637
24978723
+
TJP2
chr9
69121264
69274615
+
CLIC4
chr1
24745382
24844321
+
miRNA targets:NA
circRNA targets:NA
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC124068.2
chr15
89335053
89336161
+
AD000090.1
chr19
35557956
35581954
+
AL122017.1
chr6
81527102
81534915
-
BX284668.2
chr1
16870945
16883659
+
ZNF236-DT
chr18
76794732
76822295
-
Display:



Experiment Detail

GEO ID:GSE16176
Sample Source:Amniotic Fluid
Source Fraction:Supernatant
Platform:GPL570
Method:Microarray
Num of detected RNA Type:1
Num of detected RNAs of this Type:17063
Sample treatment protocol:NA
RNA Extract protocol:RNA was extracted from 10 mL AF with 30 mL TRIzol LS Reagent (Invitrogen, Carlsbad, CA) and 8 mL chloroform. After RNA extraction, RNA was purified and DNA was removed using the RNeasy® Maxi Kit, including the DNase step according to the manufacturer's protocol (QIAGEN, Valencia, CA). RNA was precipitated using 3M NaOAc and 100% ethanol, and 80% ethanol was added after 4 hours incubation at -20 °C. cDNA, synthesized from extracted RNA, was amplified and purified using the WT-Ovation™ Pico RNA Amplification System (NuGEN, San Carlos, CA) and the DNA Clean & Concentrator™-25 (Zymo Research, Orange, CA).
RNA library preparation protocol:biotin Samples were labeled using the FL-Ovation™ cDNA Biotin Module V2 (NuGEN, San Carlos, CA).



Reference

PMID:19474297
Title:Functional genomic analysis of amniotic fluid cell-free mRNA suggests that oxidative stress is significant in Down syndrome fetuses
Author:Slonim DK, Koide K, Johnson KL, Tantravahi U, Cowan JM, Jarrah Z, Bianchi DW
Journal:Proc Natl Acad Sci U S A. 2009 Jun 9;106(23):9425-9.
Description:To characterize the differences between second trimester Down syndrome (DS) and euploid fetuses, we used Affymetrix microarrays to compare gene expression in uncultured amniotic fluid supernatant samples.